SlideShare una empresa de Scribd logo
1 de 94
Bioavailability  Of  Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
Bioavailability Of Disperse Dosage Forms ,[object Object],[object Object],[object Object],[object Object],[object Object]
Relative Bioavailability ,[object Object],[object Object]
RBA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Absolute Bioabavailability ,[object Object],[object Object],[object Object]
Absolute Bioavailability ,[object Object],[object Object],[object Object],[object Object]
Difference between Absolute and Relative  Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
AB vs RBA   Drug Product AUC ( mcg/ml . hr ) A  IV Injection 100 B  Oral dosage form (Refer) 50 C  Oral dosage form (generic) 40
Bioequivalent Drug Products ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Disperse Systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Routes Of Drug Administration ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Properties Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Advantages Of Disperse Dosage Form ,[object Object],[object Object],[object Object],[object Object]
Formulation Factors Affecting Drug Release  From Disperse Systems : ,[object Object],[object Object],[object Object],[object Object],[object Object]
Wetting ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object]
Particle Size ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object]
Viscosity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug release from disperse systems ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Absorption Barriers   ,[object Object],[object Object]
Barriers for Skin
Barriers For Skin ,[object Object],[object Object],[object Object],[object Object]
pathways for percutaneous absorption: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Barriers For Eye
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For Eye ,[object Object],[object Object],[object Object]
Barriers For GIT
Barriers For GIT ,[object Object],[object Object],[object Object],[object Object]
Barriers for GIT ,[object Object],[object Object]
Barrier for Pulmonary Drug Delivery   ,[object Object],[object Object],[object Object],[object Object]
Barriers for Pulmonary Drug Delivery ,[object Object],[object Object],[object Object]
Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium  Epithelium  Thickness  8-26 layers  5-6 layers  1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
Physiological Factors Affecting Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Factors affecting Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Percutaneous Absorption ,[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting Ophthalmic Absorption ,[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Factors affecting G.I.T Absorption ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
pH ,[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object],[object Object],[object Object]
Metabolism ,[object Object],[object Object]
Presence Of Food ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Presence Of Food ,[object Object],[object Object]
Individual variation ,[object Object],[object Object],[object Object],[object Object]
Gender ,[object Object],[object Object]
Race ,[object Object],[object Object],[object Object]
Example ,[object Object],[object Object],[object Object],[object Object]
Age ,[object Object],[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object]
Methods Of Assessing Bioavailability Of Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object]
Plasma Drug Concentration ,[object Object],[object Object],[object Object]
Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
Key Parameters: ,[object Object],[object Object],[object Object],[object Object],[object Object]
AUC
Peak height or C max ,[object Object],[object Object],[object Object]
Time of occurrence or t max ,[object Object],[object Object],[object Object]
(2) Urinary Drug excretion Data ,[object Object],[object Object],[object Object]
Urinary Drug excretion
(3)   Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect ,[object Object],[object Object],[object Object]
Acute pharmacodynamic or pharmacologic effect
(4)   Clinical Observations ,[object Object],[object Object],[object Object]
(5)   In vitro Bioavailability studies ,[object Object],[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability ,[object Object],[object Object],[object Object]
Gastrointestinal Bioavailability Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object],[object Object]
Oral suspension ,[object Object],[object Object]
Oral emulsion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dermatological Bioavailability ,[object Object],[object Object],[object Object],[object Object],[object Object]
Measurement of Dermatological bioavailability ,[object Object],[object Object],[object Object],[object Object]
Procedure:  ,[object Object],[object Object],[object Object]
Ophthalmic Bioavailability ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object],[object Object]
Ophthalmic suspensions :   ,[object Object],[object Object]
Ophthalmic suspensions : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object]
Ophthalmic ointments : ,[object Object],[object Object],[object Object]
Ophthalmic ointments : ,[object Object]
Rectal bioavailability : ,[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object],[object Object],[object Object]
Rectal suppositories : ,[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Buccal drug delivery
Buccal drug delivery Buccal drug delivery
Buccal drug delivery
 
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGN
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGNBIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGN
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGN
 
Colon drug delivery system ppt
Colon drug delivery system pptColon drug delivery system ppt
Colon drug delivery system ppt
 
Brain Specific drug delivery
Brain Specific drug deliveryBrain Specific drug delivery
Brain Specific drug delivery
 
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
 
Solid state manipulation
Solid state manipulationSolid state manipulation
Solid state manipulation
 
Microsphere & microcapsules
Microsphere & microcapsulesMicrosphere & microcapsules
Microsphere & microcapsules
 
Bio/Mucoadhesive drug deivery system
Bio/Mucoadhesive drug deivery systemBio/Mucoadhesive drug deivery system
Bio/Mucoadhesive drug deivery system
 
Approaches To Extend GI Transit
Approaches To Extend GI TransitApproaches To Extend GI Transit
Approaches To Extend GI Transit
 
Colonic drug delivery system
Colonic drug delivery systemColonic drug delivery system
Colonic drug delivery system
 
A PPT on Non-linear Pharmacokinetics
A PPT on Non-linear PharmacokineticsA PPT on Non-linear Pharmacokinetics
A PPT on Non-linear Pharmacokinetics
 
Non Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic ParametersNon Invasive Methods Of Estimating Pharmacokinetic Parameters
Non Invasive Methods Of Estimating Pharmacokinetic Parameters
 
Colon targeted drug delivery systems
Colon targeted drug delivery systems Colon targeted drug delivery systems
Colon targeted drug delivery systems
 
DISSOLUTION AND MECHANISM OF DRUG RELEASE
 DISSOLUTION AND MECHANISM OF DRUG RELEASE DISSOLUTION AND MECHANISM OF DRUG RELEASE
DISSOLUTION AND MECHANISM OF DRUG RELEASE
 
Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis Properties of GI tract, pH partition hypothesis
Properties of GI tract, pH partition hypothesis
 
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
 
Role of Dosage Forms on absorption.
Role of Dosage Forms on absorption.Role of Dosage Forms on absorption.
Role of Dosage Forms on absorption.
 
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
Dissolution study-Dissolution studies Factor affecting dissolution and Invitr...
 
Microspheres
MicrospheresMicrospheres
Microspheres
 
Similarity factor, higuchi plot, peppas plot
Similarity factor, higuchi plot, peppas plotSimilarity factor, higuchi plot, peppas plot
Similarity factor, higuchi plot, peppas plot
 

Similar a Bioavailability Of Disperse Dosage Form

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012
eckotanglao
 

Similar a Bioavailability Of Disperse Dosage Form (20)

Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012Diffusion finals, feb 29, 2012
Diffusion finals, feb 29, 2012
 
Ndds
NddsNdds
Ndds
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Buccal drug delivery systems
Buccal drug delivery systemsBuccal drug delivery systems
Buccal drug delivery systems
 
Ocular bioavailability
Ocular bioavailabilityOcular bioavailability
Ocular bioavailability
 
Controlled release oral drug delivery
Controlled release oral drug deliveryControlled release oral drug delivery
Controlled release oral drug delivery
 
ocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriersocular barriers and methods to overcome barriers
ocular barriers and methods to overcome barriers
 
mucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptxmucoadhesive drug delivery system.pptx
mucoadhesive drug delivery system.pptx
 
Ocular drug delivery systems
Ocular drug delivery systemsOcular drug delivery systems
Ocular drug delivery systems
 
Orodispersible liquisolid compacts
Orodispersible liquisolid compactsOrodispersible liquisolid compacts
Orodispersible liquisolid compacts
 
Formulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspensionFormulation and evaluation of rosiglitazone nanosuspension
Formulation and evaluation of rosiglitazone nanosuspension
 
Jaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery SystemJaideep Sarkar- Buccomucosal Drug Delivery System
Jaideep Sarkar- Buccomucosal Drug Delivery System
 
Lec 4 & 5
Lec 4 & 5Lec 4 & 5
Lec 4 & 5
 
General pharmacology
General pharmacologyGeneral pharmacology
General pharmacology
 
Dissolution
DissolutionDissolution
Dissolution
 
ocular drug delivery
ocular drug deliveryocular drug delivery
ocular drug delivery
 
Ocular Drug Delivery System.pptx
Ocular Drug Delivery System.pptxOcular Drug Delivery System.pptx
Ocular Drug Delivery System.pptx
 
Unit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdfUnit III_Transdermal DDS.pdf
Unit III_Transdermal DDS.pdf
 
Mechanism of dds1
Mechanism of dds1Mechanism of dds1
Mechanism of dds1
 
Drug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptxDrug Absorption(Ver 20.0).pptx
Drug Absorption(Ver 20.0).pptx
 

Último

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 

Último (20)

Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 

Bioavailability Of Disperse Dosage Form

  • 1. Bioavailability Of Disperse Dosage Forms By Mohammad Sohail Mphil pharmaceutics Islamia university Bahawalpur [email_address]
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8. AB vs RBA Drug Product AUC ( mcg/ml . hr ) A IV Injection 100 B Oral dosage form (Refer) 50 C Oral dosage form (generic) 40
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 24.
  • 25.
  • 27.
  • 28.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. Absorption Factors SKIN EYE GIT Barrier Stratum corneum Superficial layer of epithelium Epithelium Thickness 8-26 layers 5-6 layers 1 layer hydration 10-25% 78% High area 2-25cm 2 1.3cm 2 2,000,000
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45. pH Location pH Stomach Duodenum Jejunum Ileum Colon Rectum 1.5-3.5 5-7 6-7 6.0-7.5 5.5-7.0 7
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60. Plasma concentration vs. time profile of a single dose of a drug ingested orally Plasma Concentration
  • 61.
  • 62. AUC
  • 63.
  • 64.
  • 65.
  • 67.
  • 68.
  • 69. Acute pharmacodynamic or pharmacologic effect
  • 70.
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.